Laura Leber is CCO at GENOMIC HEALTH INC (GHDX). They have made 8 open-market trades across 1 company since 2015, most recently 2019-11-08.
CIK 0001649191
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GHDX | 9,384 | $595K |
Shares reported on the most recent Form 4, priced at the 2019-11-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GHDX | SELL | 2019-10-17 | 2019-10-21 | $70.94 | $1.9M | -3.9% | N/A | N/A |
| GHDX | SELL | 2019-02-21 | 2019-02-22 | $80.24 | $452K | -10.4% | -13.9% | -35.2% |
| GHDX | SELL | 2019-02-20 | 2019-02-22 | $82.26 | $4.0M | -10.4% | -13.9% | -35.2% |
| GHDX | SELL | 2019-02-20 | 2019-02-22 | $82.87 | $1.6M | -10.4% | -13.9% | -35.2% |
| GHDX | SELL | 2018-02-20 | 2018-02-22 | $32.90 | $215K | +1.7% | +0.5% | +22.0% |
| GHDX | SELL | 2017-12-14 | 2017-12-18 | $33.29 | $699K | -7.1% | -5.3% | -11.4% |
| GHDX | SELL | 2017-03-20 | 2017-03-22 | $31.88 | $196K | +0.3% | +0.5% | +5.2% |
| GHDX | SELL | 2016-11-21 | 2016-11-23 | $31.73 | $334K | -1.9% | -3.7% | -8.8% |
| GHDX | SELL · 10b5-1 | 2015-12-07 | 2015-12-09 | $29.33 | $123K | -10.0% | -7.5% | -23.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.